Jodi Devlin, Chief of Clinical Operations at TriSalus Life Sciences, Inc. (TLSI), sold 4,764 shares at $5.18 ($25K) on 2025-05-19, disclosed to the SEC on 2025-05-21.
Open-market sale of $25k TLSI by Chief of Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.